Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 37 citing Werner: The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases.... (0.12 sec) 

Endothelial progenitor cells in neovascularization of infarcted myocardium

- nih.gov
K Jujo, M Ii, DW Losordo - Journal of molecular and cellular cardiology, 2008 - Elsevier
Historically, revascularization of ischemic tissue was believed to occur through
the migration and proliferation of endothelial cells in nearby tissues; however,
evidence accumulated in recent years indicates that a subpopulation of ...
Cited by 20 - Related articles - All 16 versions

Adiponectin promotes endothelial progenitor cell number and function

- nih.gov
R Shibata, C Skurk, N Ouchi, G Galasso, K … - FEBS letters, 2008 - Elsevier
Obesity-linked diseases are associated with suppressed endothelial progenitor
cell (EPC) function. Adiponectin is an adipose-derived protein that is
downregulated in obese and diabetic subjects. Here, we investigated the ...
Cited by 10 - Related articles - All 5 versions

Endothelial progenitor cells: Implications for cardiovascular disease


S Möbius-Winkler, R Höllriegel, G Schuler, V … - System, 1927 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 9 - Related articles - All 3 versions

Peroxisome proliferator-activated receptor-γ ligands: potential pharmacological agents for …


G Costas, T Anna, T Stamatios - PPAR research, 2008 - hindawi.com
Peroxisome proliferator-activated receptor- γ (PPAR- γ ) has currently been
considered as molecular target for the treatment of human metabolic disorders.
Experimental data from in vitro cultures, animal models, and clinical ...
Cited by 7 - Related articles - Cached - All 9 versions

Glitazones and the cardiovascular system

- nursing2008.com
PR Devchand - Current Opinion in Endocrinology, Diabetes and …, 2008 - journals.lww.com
Recent findings: Several classes of oral antidiabetic drugs are available to
treat type 2 diabetes, but glitazones offer the unique promise of
insulin-sensitizing ability coupled with potential to reverse ...
Cited by 6 - Related articles - BL Direct - All 5 versions

Induction of CXCR2 Receptor by Peroxisome Proliferator-Activated Receptor {gamma} in …

- ahajournals.org
E Rigamonti, C Fontaine, B Lefebvre, C Duhem … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2008 - Am Heart Assoc
Objective— Macrophages play a central role in the immune response against
infectious organisms. Once activated, macrophages secrete proinflammatory
cytokines and chemokines. Interleukin (IL)-8 and related CXC chemokines ...
Cited by 3 - Related articles - All 5 versions

Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery …


SR Patel, LM Mailloux, JT Coppola, C … - Coronary artery disease, 2008 - journals.lww.com
Objectives Hypoadiponectinemia is associated with coronary artery disease (CAD).
Pioglitazone has been shown to increase levels of adiponectin in diabetic
patients. We sought to assess whether administration of pioglitazone to ...
Cited by 2 - Related articles - All 5 versions

PPARs and the cardiovascular system


M Hamblin, L Chang, Y Fan, J Zhang, YE … - Antioxidants & Redox Signaling, 2009 - liebertonline.com
Page 1. Comprehensive Invited Review PPARs and the Cardiovascular System Milton
Hamblin, Lin Chang, Yanbo Fan, Jifeng Zhang, and Y. Eugene Chen ...
Cited by 1 - Related articles - All 2 versions

Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients


H Makino, S Okada, A Nagumo, T Sugisawa, Y … - Diabetes Research and Clinical Practice, 2008 - Elsevier
Circulating bone marrow derived immature cells, including CD34-positive (CD34 +
) cells, contribute to maintenance of the vasculature, not only as a pool of
endothelial progenitor cells (EPCs), but also as a source of ...
Cited by 1 - Related articles - All 21 versions

Impact of pioglitazone on coronary endothelial function in non-diabetic patients with …


J Wöhrle, N Marx, W Koenig, V Hombach, HA … - Clinical Research in Cardiology, 2008 - Springer
Pioglitazone, a peroxisome proliferator-activated receptor c (PPARc) activating
thiazolidinedione (TZD) is used for treatment of patients with type 2 diabetes
[24, 37]. Several lines of evidence indicate that PPARc stimulation with ...
Cited by 1 - Related articles - All 2 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google